Zura Bio Ltd (STU:94E) Stock News, Headlines & Updates
Zura Bio Ltd Stock News from GuruFocus
- 1
Jun 14, 2024
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
Business Wire • 6:00am
Jun 06, 2024
Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology
Business Wire • 6:00am
Jun 03, 2024
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
Business Wire • 6:00am
May 29, 2024
Zura Bio Announces Participation in June Investor Conferences
Business Wire • 6:00am
May 10, 2024
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus Research • 1:14pm
Apr 25, 2024
Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA)
GuruFocus Research • 12:18am
Apr 18, 2024
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Business Wire • 9:00am
Apr 08, 2024
Zura Bio Announces Robert Lisicki as CEO and Director
Business Wire • 6:00am
Apr 01, 2024
Zura Bio Ltd (ZURA) Reports Full Year 2023 Financial Results Amidst Leadership Transition
GuruFocus Research • 7:01pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news